Principal Investigator Dr. Joel Saper is conducting a clinical research study evaluating an investigational medication for the prevention of migraine headaches. The study medication is being compared to placebo. You will have a 40% chance of receiving placebo. The study medication is given as subcutaneous (under the skin) injections 6 times in the study. The study is about 35 weeks in duration and requires 15 visits to our Institute in Ann Arbor, MI
To qualify for this study, individuals must:
- be between 18 and 60 years of age
- experience > 4 migraine days per month
- meet other study eligibility criteria
If you qualify, you will receive study-required exams and study medication at no cost to you. In addition, you may be compensated for your time and travel expenses.
Please complete the following profile and a Research Nurse will contact you.